It only took until 2013, but the US Food and Drug Administration finally secured guilty pleas and fines. The basics are in an Associated Pr...
Showing posts with label adverse effects. Show all posts
Showing posts with label adverse effects. Show all posts
Six Years Later, Ranbaxy - Oops, Daiichi Sankyo - Pleads Guilty to Adulteration, Pays $500 Million
It only took until 2013, but the US Food and Drug Administration finally secured guilty pleas and fines. The basics are in an Associated Pr...
Amgen CEOs Prosper Despite (or Because of) Continuing Ethical Questions
This is becoming a familiar narrative on Health Care Renewal : top health care leaders continue to enrich themselves while their organizati...
Deadly Over-Doses and Private Equity - the Case of Bain Capital's Methadone Clinics
Some reporting by Bloomberg provides more evidence about what happens when direct care of the most vulnerable patients is commercialized. T...
How the "Revolving Door" and Other Aspects of Corporatism Benefited Amgen Just After its Settlement and Guilty Plea
At least here in these United States, our health care corporatism is bipartisan. Here we present a sorry story of how a company that should...
Amgen Settles, Pleads Guilty to Misbranding Aranesp
Now it's Amgen's turn to settle and plead. Per the New York Times, The biotechnology giant Amgen marketed its anemia drug Aranesp ...
Back to the Future - Another Medical Device Company Accused of Hiding ICD Defects
Suppression of data about defects in and failures of implantable cardiac defibrillators (ICDs) was one of the big issues we featured in the ...
More Hospices Pretending Patients are Terminally Ill
In the US, we have been engaged in an experiment involving handing over an ever increasing proportion of direct patient care to for-profit c...
Who Really Makes Brand-Name Pharmaceuticals?
A striking illustration of the hazards to patients' and the public's health from health care organizational leaders using fashionabl...
